In vivo biology and toxicology of fullerenes and their derivatives

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 3, 2008, Pages 197-208

  Nielsen, Gunnar Damgård ^a   Roursgaard, Martin ^a   Jensen, Keld Alstrup ^a   Poulsen, Steen Seier ^b   Larsen, Søren Thor ^a  

^a NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; FULLERENE; FULLERENE DERIVATIVE; METHAMPHETAMINE; MORPHINE; NANOPARTICLE; REACTIVE OXYGEN METABOLITE;

AGING; AUTOMUTILATION; BIOACCUMULATION; BIOLOGY; CARCINOGENIC ACTIVITY; DNA DAMAGE; GENOTOXICITY; HALF LIFE TIME; HUMAN; NONHUMAN; OSTEOARTHRITIS; PHOTOTOXICITY; PRIORITY JOURNAL; RADIATION PROTECTION; REPERFUSION INJURY; REPRODUCTIVE TOXICITY; SHORT SURVEY; SKIN TOXICITY; TOXICOLOGY;

ANIMALS; FULLERENES; HUMANS; NANOPARTICLES;

ANIMALIA;

EID: 49749112333     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00266.x     Document Type: Short Survey

References (80)

1. Service RF. Nanotoxicology: nanotechnology grows up. Science 2004 304 : 1732 4.
2. Aitken RJ, Chaudhry MQ, Boxall ABA, Hull M. Manufacture and use of nanomaterials: current status in the UK and global trends. Occup Med 2006 56 : 300 6.
3. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005 113 : 823 39.
4. Nohynek GJ, Lademann J, Ribaud C, Roberts MS. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 2007 37 : 251 77.
5. Jain KK. The role of nanobiotechnology in drug discovery. Drug Discov Today 2005 10 : 1435 42.
6. Suri SS, Fenniri H, Singh B. Nanotechnology-based drug delivery systems. J Occup Med Toxicol 2007 2 : 16.
7. Plitzko S, Gierke E. Tätigkeiten mit Nanomaterialien in Deutschland. Gefahrstoffe - Reinhaltung der Luft 2007 67 : 419 24.
8. Thompson BC, Frechet JMJ. Organic photovoltaics - Polymer-fullerene composite solar cells. Angew Chem Int Ed Engl 2008 47 : 58 77.
9. 60, a novel carbon allotrope, and its derivatives. J Pharm Sci 2006 100 : 513 8.
10. Djordjevic A, Bogdanovic G, Dobric S. Fullerenes in biomedicine. J BUON 2006 11 : 391 404.
11. 60: buckminsterfullerene. Nature 1985 318 : 162 3.
12. Lee VS, Nimmanpipug P, Aruksakunwong O, Promsri S, Sompornpisut P, Hannongbua S. Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations. J Mol Graph Model 2007 26 : 558 70.
13. 60: buckminsterfullerene. Chem Rev 1991 91 : 1213 35.
14. Dugan LL, Gabrielsen JK, Yu SP, Lin TS, Choi DW. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis 1996 3 : 129 35.
15. Wang JX, Chen CY, Li B, Yu HW, Zhao YL, Sun J et al. Antioxidative function and biodistribution of [Gd@C-82(OH)(22)](n) nanoparticles in tumor-bearing mice. Biochem Pharmacol 2006 71 : 872 81.
16. Taylor R, Walton DRM. The chemistry of fullerenes. Nature 1993 363 : 685 93.
17. 60 in solvent mixtures. Environ Sci Technol 2008 42 : 845 51.
18. 60 fullerenes through a lipid membrane: a molecular dynamics simulation study. J Phys Chem B 2008 112 : 2078 84.
19. 60. Science 1991 254 : 1183 5.
20. 22 on doxorubicin-induced cytotoxicity. Toxicol In Vitro 2004 18 : 629 37.
21. Fukuzumi S. Catalysis in electron transfer reactions: facts and mechanistic insights. J Phys Org Chem 2002 15 : 448 60.
22. Murr LE, Soto KF, Garza KM, Guerrero PA, Martinez F, Esquivel EV et al. Combustion-generated nanoparticulates in the El Paso, TX, USA/Juarez, Mexico Metroplex: their comparative characterization and potential for adverse health effects. Int J Environ Res Public Health 2006 3 : 48 66.
23. Jensen AW, Wilson SR, Schuster DI. Biological applications of fullerenes. Bioorg Med Chem 1996 4 : 767 79.
24. Bosi S, Da Ros T, Spalluto G, Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 2003 38 : 913 23.
25. 60-fullerene adducts. Arch Biochem Biophys 2000 378 : 216 23.
26. 60- fullerene monomalonate adducts selectively inactivate neuronal nitric oxide synthase by uncoupling the formation of reactive oxygen intermediates from nitric oxide production. Biochemistry 2001 40 : 37 45.
27. 60, fullerenols, as glutamate receptor antagonists and neuroprotective agents. J Neurosci Res 2000 62 : 600 7.
28. Bosi S, Feruglio L, Da Ros T, Spalluto G, Gregoretti B, Terdoslavich M et al. Hemolytic effects of water-soluble fullerene derivatives. J Med Chem 2004 47 : 6711 5.
29. 60 tris-adduct on Jurkat cells. J Photochem Photobiol B 2002 67 : 157 62.
30. Tabata Y, Murakami Y, Ikada Y. Photodynamic effect of polyethylene glycol-modified fullerene on tumor. Jpn J Cancer Res 1997 88 : 1108 16.
31. Isakovic A, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Mirkovic M et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 2006 91 : 173 83.
32. 60 derivative on hydrogen peroxide-induced apoptosis in rat pheochromocytoma PC12 cells. Chem Biol Interact 2007 167 : 135 44.
33. 60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development. Arthritis Rheum 2007 56 : 3307 18.
34. Quick KL, Ali SS, Arch R, Xiong C, Wozniak D, Dugan LL. A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol Aging 2008 29 : 117 28.
35. Lin AMY, Fang SF, Lin SZ, Chou CK, Luh TY, Ho LT. Local carboxyfullerene protects cortical infarction in rat brain. Neurosci Res 2002 43 : 317 21.
36. Mori T, Ito S, Kita T, Narita M, Suzuki T, Matsubayashi K et al. Oxidative stress in methamphetamine-induced self-injurious behavior in mice. Behav Pharmacol 2007 18 : 239 49.
37. Mori T, Ito S, Namiki M, Suzuki T, Kobayashi S, Matsubayashi K et al. Involvement of free radicals followed by the activation of phospholipase A(2) in the mechanism that underlies the combined effects of methamphetamine and morphine on subacute toxicity or lethality in mice: comparison of the therapeutic potential of fullerene, mepacrine, and cooling. Toxicology 2007 236 : 149 57.
38. Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson SR, Moussa F. [60]Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett 2005 5 : 2578 85.
39. n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett 2005 5 : 2050 7.
40. Daroczi B, Kari G, McAleer MF, Wolf JC, Rodeck U, Dicker AP. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model. Clin Cancer Res 2006 12 : 7086 91.
41. Sayes CM, Fortner JD, Guo W, Lyon D, Boyd AM, Ausman KD et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 2004 4 : 1881 7.
42. 60 cytotoxicity is due to lipid peroxidation. Biomaterials 2005 26 : 7587 95.
43. Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJAM. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 2007 49 : 217 29.
44. 60 and its derivatives across a lipid bilayer. Nano Lett 2007 7 : 614 9.
45. 60 nanoparticles by protein adsorption and its implications for toxicity studies. Chem Res Toxicol 2007 20 : 854 8.
46. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006 6 : 1794 807.
47. 60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution electron microscopy and electron tomography. Acta Biomater 2006 2 : 409 19.
48. Rouse JG, Yang JZ, Ryman-Rasmussen JP, Barron AR, Monteiro-Riviere NA. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett 2007 7 : 155 60.
49. van Ravenzwaay B, Leibold E. A comparison between in vitro rat and human and in vivo rat skin absorption studies. Hum Exp Toxicol 2004 23 : 421 30.
50. Florence AT. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res 1997 14 : 259 66.
51. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001 46 : 3 26.
52. 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol 1995 2 : 385 9.
53. Doyle-McCullough M, Smyth SH, Moyes SM, Carr KE. Factors influencing intestinal microparticle uptake in vivo. Int J Pharm 2007 335 : 79 89.
54. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002 65 : 1531 43.
55. Peters A, Veronesi B, Calderon-Garciduenas L, Gehr P, Chen LC, Geiser M et al. Translocation and potential neurological effects of fine and ultrafine particles: a critical update. Part Fibre Toxicol 2006 3 : 13.
56. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004 16 : 437 45.
57. 60 fullerene nanoparticles and microparticles. Toxicol Sci 2008 101 : 122 31.
58. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdorster G et al. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 2004 16 : 453 9.
59. Takenaka S, Karg E, Kreyling WG, Lentner B, Moller W, Behnke-Semmler M et al. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 2006 18 : 733 40.
60. Muhlfeld C, Geiser M, Kapp N, Gehr P, Rothen-Rutishauser B. Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the 'relative deposition index': evidence for clearance through microvasculature. Part Fibre Toxicol 2007 4 : 7
61. Rajagopalan P, Wudl F, Schinazi RF, Boudinot FD. Pharmacokinetics of a water-soluble fullerene in rats. Antimicrob Agents Chemother 1996 40 : 2262 5.
62. x in mice. J Nanoparticle Res 2006 8 : 53 63.
63. 60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 2004 112 : 1058 62.
64. 60 nano-aggregates to tetrahydrofuran decomposition products in larval zebrafish by assessment of gene expression. Environ Health Perspect 2007 115 : 1059 65.
65. Rouse JG, Yang JZ, Barron AR, Monteiro-Riviere NA. Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol In Vitro 2006 20 : 1313 20.
66. Yamawaki H, Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol 2006 290 : C1495 502.
67. Huczko A, Lange H, Calko E. Fullerenes: experimental evidence for a null risk of skin irritation and allergy. Fullerene Sci Technol 1999 7 : 935 9.
68. Mori T, Takada H, Ito S, Matsubayashi K, Miwa N, Sawaguchi T. Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. Toxicology 2006 225 : 48 54.
69. 60 in rats. Toxicol Pathol 1998 26 : 143 51.
70. 60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett 2007 7 : 2399 406.
71. 60. Toxicol Lett 1997 93 : 29 37.
72. Tsuchiya T, Oguri I, Yamakoshi YN, Miyata N. Novel harmful effects of [60] fullerene on mouse embryos in vitro and in vivo. FEBS Lett 1996 393 : 139 45.
73. 60) and fullerol. Environ Toxicol Chem 2007 26 : 976 9.
74. Schins RPF. Mechanisms of genotoxicity of particles and fibers. Inhal Toxicol 2002 14 : 57 78.
75. 60-generated singlet oxygen dependent formation of lipid peroxides. Carcinogenesis 1996 17 : 2163 9.
76. 60 fullerenes in water: evidence for genotoxicity. Environ Sci Technol 2006 40 : 7394 401.
77. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006 160 : 1 40.
78. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006 72 : 1605 21.
79. Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 2008 11 : 1 15.
80. Nelson MA, Domann FE, Bowden GT, Hooser SB, Fernando Q, Carter DE. Effects of acute and subchronic exposure of topically applied fullerene extracts on the mouse skin. Toxicol Ind Health 1993 9 : 623 30.